Related Experiment Videos
Aminoglycoside antibiotics in clinical use
1Temple University School of Medicine, Philadelphia, Pennsylvania.
The Medical Clinics of North America
|May 1, 1988
Summary
Aminoglycosides remain vital antibiotics due to their effectiveness against resistant gram-negative bacteria. Despite risks like nephrotoxicity and ototoxicity, their benefits often outweigh these drawbacks, ensuring their continued use.
Area of Science:
- Pharmacology and Microbiology
- Infectious Diseases
Background:
- Aminoglycosides are widely utilized antibiotics, facing competition from beta-lactam agents.
- Decades of research have established their activity, pharmacology, and toxicity profiles.
- Key limitations include nephrotoxicity, ototoxicity, and the need for drug level monitoring.
Purpose of the Study:
- To review the established role and future prospects of aminoglycoside antibiotics.
- To highlight the balance between aminoglycoside benefits and risks.
Main Methods:
- Literature review and synthesis of existing data on aminoglycoside antibiotics.
- Analysis of clinical utility, resistance patterns, and adverse effects.
Main Results:
- Aminoglycosides exhibit significant activity against antibiotic-resistant gram-negative bacteria.
- Nephrotoxicity and ototoxicity are significant concerns associated with aminoglycoside use.
- Drug level monitoring is essential but adds to treatment costs.
Conclusions:
- The potent activity of aminoglycosides against resistant pathogens justifies their continued clinical use.
- Careful monitoring and management are crucial to mitigate toxicity risks.
- Aminoglycosides are expected to remain important therapeutic options for the foreseeable future.